REPRIEVE Clinical Trial to Prevent Heart Disease in People Living with HIV

Details

2017-11-23 04:00:00
Daily

Location Info:

Multiple Locations
Multiple Locations
Greater Los Angeles, California  90001
415-512-0151

Promotional Event Description

REPRIEVE Clinical Trial to Prevent Heart Disease in People Living with HIV

People living with HIV are 50–100% more likely to develop heart disease (including heart attack and stroke) than people without HIV. REPRIEVE testing whether a daily dose of a FDA approved statin medication (pitavastatin) lowers the risk of heart related disease in people living with HIV. We need HIV+ volunteers between the ages of 40 and 75 to be a part of this study. YOUR participation will help us understand ways to prevent heart-related disease in women and men living with HIV.

Newsletters

All-access pass to the top stories, events and offers around town.

  • Top Stories
    Send:

Newsletters

All-access pass to top stories, events and offers around town.

Sign Up >

No Thanks!

Remind Me Later >